These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37266535)

  • 21. Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center.
    Chung LY; Kang E; Nam HK; Rhie YJ; Lee KH
    J Korean Med Sci; 2021 Aug; 36(34):e219. PubMed ID: 34463062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of subcutaneous administration of gonadotropin-releasing hormone agonist on idiopathic central precocious puberty.
    Liang Y; Wei H; Zhang J; Hou L; Luo X
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):558-61. PubMed ID: 17219967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.
    Carel JC; Blumberg J; Seymour C; Adamsbaum C; Lahlou N;
    Eur J Endocrinol; 2006 Jan; 154(1):119-24. PubMed ID: 16382000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The histrelin implant: a novel treatment for central precocious puberty.
    Hirsch HJ; Gillis D; Strich D; Chertin B; Farkas A; Lindenberg T; Gelber H; Spitz IM
    Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty.
    Klein KO; Freire A; Gryngarten MG; Kletter GB; Benson M; Miller BS; Dajani TS; Eugster EA; Mauras N
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3660-71. PubMed ID: 32738042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of Puberty Suppression with Gonadotropin-Releasing Hormone Agonists in Transgender Youth.
    Mejia-Otero JD; White P; Lopez X
    Transgend Health; 2021; 6(1):31-35. PubMed ID: 33614957
    [No Abstract]   [Full Text] [Related]  

  • 27. Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty.
    Schubert S; Hvelplund AH; Handberg A; Hagstroem S; Leunbach TL
    J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):204-211. PubMed ID: 33374097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Acting Gonadotropin-Releasing Hormone Analogues for Central Precocious Puberty, Including 45-Mg 6-Month Subcutaneous Leuprolide Acetate: Use for Treatment and Treatment Monitoring.
    Silverman LA; Geffner ME; Benson M
    Horm Res Paediatr; 2024 Apr; ():1-8. PubMed ID: 38653206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty.
    Klein K; Yang J; Aisenberg J; Wright N; Kaplowitz P; Lahlou N; Linares J; Lundström E; Purcea D; Cassorla F
    J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1241-1248. PubMed ID: 26887034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone.
    Vottero A; Pedori S; Verna M; Pagano B; Cappa M; Loche S; Bernasconi S; Ghizzoni L
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1284-7. PubMed ID: 16449342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.
    Pucarelli I; Segni M; Ortore M; Arcadi E; Pasquino AM
    J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1005-10. PubMed ID: 14513877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment with gonadotropin-releasing hormone analogs (GnRHa) in childhood and adolescence].
    Comité Nacional de Endocrinología
    Arch Argent Pediatr; 2022 Feb; 120(1):S1-S8. PubMed ID: 35068132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
    Neely EK; Hintz RL; Parker B; Bachrach LK; Cohen P; Olney R; Wilson DM
    J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty.
    Lee PA; Klein K; Mauras N; Neely EK; Bloch CA; Larsen L; Mattia-Goldberg C; Chwalisz K
    J Clin Endocrinol Metab; 2012 May; 97(5):1572-80. PubMed ID: 22344198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women.
    Li Z; Zhang HY; Zhu YJ; Hu YJ; Qu PP
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():164-8. PubMed ID: 25461372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
    Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the Subcutaneous Triptorelin Stimulation Test for Diagnosis of Central Precocious Puberty.
    Ahn J; Lee Y; Gim S; Jeong H
    Children (Basel); 2023 Nov; 10(11):. PubMed ID: 38002921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin and Estradiol Levels after Leuprolide Stimulation Tests in Brazilian Girls with Precocious Puberty.
    Junqueira FR; Lara LA; Martins WP; Ferriani RA; Rosa-E-Silva AC; de Sá MF; Reis RM
    J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):313-6. PubMed ID: 26094907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter clinical trial of leuprolide acetate depot (Luphere depot 3.75 mg) for efficacy and safety in girls with central precocious puberty.
    Kim YJ; Lee HS; Lee YJ; Lim JS; Kim SY; Kim EY; Jin DK; Hwang IT; Hwang JS
    Ann Pediatr Endocrinol Metab; 2013 Dec; 18(4):173-8. PubMed ID: 24904873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.